Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDate | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
06/29/2024 | Q2 2024 | N/A | -$0.18 | N/A | N/A | $48.94 M |
03/30/2024 | Q1 2024 | N/A | -$0.38 | N/A | N/A | $34.59 M |
12/29/2023 | Q4 2023 | N/A | -$0.26 | N/A | N/A | $36.36 M |
09/28/2023 | Q3 2023 | N/A | -$0.13 | N/A | N/A | $34.27 M |
06/28/2023 | Q2 2023 | N/A | -$0.14 | N/A | N/A | $33.47 M |
03/29/2023 | Q1 2023 | N/A | -$0.22 | N/A | N/A | $26.10 M |
12/29/2022 | Q4 2022 | N/A | $0.04 | N/A | N/A | $20.33 M |
09/28/2022 | Q3 2022 | N/A | -$0.24 | N/A | N/A | $22.82 M |
06/29/2022 | Q2 2022 | N/A | -$0.23 | N/A | N/A | $23.32 M |
03/29/2022 | Q1 2022 | N/A | -$0.09 | N/A | N/A | $22.12 M |
12/29/2021 | Q4 2021 | N/A | -$0.28 | N/A | N/A | $20.19 M |
09/28/2021 | Q3 2021 | N/A | -$0.31 | N/A | N/A | $18.71 M |
06/28/2021 | Q2 2021 | N/A | -$0.09 | N/A | N/A | $18.13 M |
03/29/2021 | Q1 2021 | N/A | $0.01 | N/A | N/A | $15.44 M |
12/30/2020 | Q4 2020 | N/A | $0.04 | N/A | N/A | $14.60 M |
09/29/2020 | Q3 2020 | N/A | $0.32 | N/A | N/A | $14.40 M |
06/29/2020 | Q2 2020 | N/A | -$0.01 | N/A | N/A | $8.06 M |
03/30/2020 | Q1 2020 | N/A | -$0.50 | N/A | N/A | $11.82 M |
12/30/2019 | Q4 2019 | N/A | $0.10 | N/A | N/A | $12.60 M |
09/29/2019 | Q3 2019 | N/A | -$0.45 | N/A | N/A | $12.76 M |
The conference call for Harrow Health, Inc. 11.875% Senior Notes due 2027's latest earnings report can be listened to online.
The conference call transcript for Harrow Health, Inc. 11.875% Senior Notes due 2027's latest earnings report can be read online.
Harrow Health, Inc. 11.875% Senior Notes due 2027 (:HROWM) has a recorded annual revenue of $130.19 M.
Harrow Health, Inc. 11.875% Senior Notes due 2027 (:HROWM) has a recorded net income of $-24,411,000.Harrow Health, Inc. 11.875% Senior Notes due 2027 has generated $-0.75 earnings per share over the last four quarters.
Harrow Health, Inc. 11.875% Senior Notes due 2027 (:HROWM) has a price-to-earnings ratio of -28.45 and price/earnings-to-growth ratio is 6.47.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED